US 10709799
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10709799 (Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K47/68031, A61K47/6849